Evonik Industries and AkzoNobel say they have entered into negotiations to build a membrane cell electrolysis production facility at AkzoNobel’s Ibbenbüren, Germany, site. The companies plan to form a joint venture to construct and operate the facility, which will produce chlorine and potassium hydroxide solution. Evonik and AkzoNobel plan to finalize negotiations by end of this year. The plan forms part of Europe’s proposal to phase out mercury cell electrolysis technology by 2018. The new plant, which will replace AkzoNobel’s...